Flax seed lignan in disease prevention and health promotion

Abstract

Lignans have been part of both diet and herbal medicines for centuries. It is only in the last half century that phytochemists have described the structures of the lignans. Pharmacologists have only become interested in the biological activity of lignans in the last few decades. Much of the early interest focused on podophyllotoxin type lignans and their derivatives. Recent literature has recorded very many new lignans or lignan derivatives with a diverse range of biological activities. In 1955, the isolation from flax seed and the structure of the lignan derivative secoisolariciresinol diglucoside (SDG) was reported. Possible biological activity of SDG, and the mammalian lignan metabolites, enterolactone and enterodiol, was initially reported about 20 years later. During the next 30 years, there has been extensive research on the biological effects of both flax seed and rye lignans since both are metabolized into the mammalian lignans. Research on the activity of lignans on breast, colon, prostate and thyroid cancer has generally shown beneficial effects although there are some studies with either no conclusive or negative effect. Lignans have been shown to have positive effects in lowering relative risk factors for heart disease. Use of flax seed or SDG has been shown to have positive effects in both lupus and polycystic kidney disease models. Studies of both type I and II diabetes models have reported positive results when using SDG. Flax seed has also been reported to be hepatoprotective. Reproductive effects have been observed with flax seed or SDG and have been found to be dose and time related. There are many possible mechanistic explanations for the observed bioactivities including involvement in hormonal metabolism or availability, angiogenesis, anti-oxidation and gene suppression. Abbreviations: ALA – alpha linolenic acid; ApcMin – adenomatous polyposis coli multiple intestinal neoplasia; BBdp – BioBreeding diabetic prone; CCl4– carbon tetrachloride; CDC – Crop Development Centre; CHD – cardiovascular heart disease; DMBA – dimethylbenzanthracene; DNA – deoxyribonucleic acid; ER – estrogen receptor; λGT –γ-glutamyltranspeptidase; HDL – high-density lipoprotein; HMGA – hydroxymethyl glutaric acid; IDDM – insulin dependent diabetes mellitus; LDL – low-density lipoprotein; MRL/lpr, Murine Lupus/lymphoproliferative; MDA – malondiadehyde; NIDDM – non-insulin dependent diabetes mellitus; ORF – oxygen free radical; PAF – platelet activating factor; PKD – Polycystic kidney disease; PEPCK – phosphoenolpyruvate carboxykinase; PMNL – polymorphonuclear monocytes; STZ – streptozoticin; TC – total cholesterol; TG – triglycerides; SDG – secoisolariciresinol diglucoside; ZDF – Zucker diabetic fatty.

This is a preview of subscription content, log in to check access.

References

  1. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3: 364–373.

    PubMed  Google Scholar 

  2. Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, Arosemena PJ, Kellis JT & Vickery LE (1993) Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Ster. Biochem. Molec. Biol. 44: 147–153.

    CAS  Google Scholar 

  3. Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR & Gorbach SL (1982) Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian post-menopausal women and in women with breast cancer. Lancet: 1295–1299.

  4. Adlercreutz H, Mousavi Y, Clark J, Hockerstedt K, Hamalainen E, Wahala K, Makela T & Hase T (1992) Dietary phytoestrogens and cancer: In vitro and in vivo studies. J. Steroid Biochem. 41: 331–337.

    CAS  Google Scholar 

  5. Axelson M & Setchell KDR (1981) The excretion of lignans in rats-evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett. 123: 337–342.

    PubMed  CAS  Google Scholar 

  6. Axelson M, Sjövall J, Gustaisson BE & Setchell KDR (1982) Origin of lignans in mammals and identification of a precursor from plants. Nature 298: 659–670.

    PubMed  CAS  Google Scholar 

  7. Bakke JE & Klosterman HJ (1956) A new diglucoside from flaxseed. Proc. North Dakota Acad. Sci. 10: 18–22.

    Google Scholar 

  8. Ban HS, Lee S, Kim YP, Yamaki K, Shin KH & Ohuchi K (2002) Inhibition of prostaglandin E(2) production by taiwanin C isolated from the root of Acanthopanax chiisanensis and the mechanism of action. Biochem. Pharmacol. 64: 1345–1354.

    PubMed  CAS  Google Scholar 

  9. Biftu T & Stevenson R (1987) Natural 2,5-bisaryl-tetrahydrofuran lignans: platelet-activating factor antagonists. Phytother. Res. 1: 97–106.

    CAS  Google Scholar 

  10. Bohnenstengel FI, Steube KG, Meyer C, Quentmeier H, Nugroho BW & Proksch P (1999) 1H-cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines. Z Naturforsch [C] 54: 1075–1083.

    CAS  Google Scholar 

  11. Bylund A, Lundin E, Zhang JX, Nordin A, Kaaks R, Stenman UH, Aman P, Adlercreutz H, Nilsson TK, Hallmans G, Bergh A & Stattin P (2003) Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur. J. Cancer Prev. 12: 407–415.

    PubMed  CAS  Google Scholar 

  12. Bylund A, Zhang JX, Bergh A, Damber JE, Widmark A, Johansson A, Adlercreutz H, Aman P, Shepherd MJ & Hallmans G (2000) Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42: 304–314.

    PubMed  CAS  Google Scholar 

  13. Canel C, Moraes RM, Dayan FE & Ferreira D (2000) Podophyllotoxin. Phytochemistry 54: 115–120.

    PubMed  CAS  Google Scholar 

  14. Carini M, Aldini G, Orioli M & Facino RM (2002) Antioxidant and photoprotective activity of a lipophilic extract containing neolignans from Krameria triandra roots. Planta Med. 68: 193–197.

    PubMed  CAS  Google Scholar 

  15. Chandrasekar B & Fernandes G (1994) Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis. Biochem. Biophys. Res. Commun. 200: 893–898.

    PubMed  CAS  Google Scholar 

  16. Chen DF, Zhang SX, Kozuka M, Sun QZ, Feng J, Wang Q, Mukainaka T, Nobukuni Y, Tokuda H, Nishino H, Wang KH, Morris-Natschke SL & Lee KH (2002a) Interiotherins C and D, two new lignans from Kadsura interior and antitumor-promoting effects of related neolignans on Epstein-Barr virus activation. J. Nat. Prod. 65: 1242–1245.

    PubMed  CAS  Google Scholar 

  17. Chen J, Stavro PM & Thompson LU (2002b) Dietary flaxseed inhibits human breast cancer growth and metastasis and down-regulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer 43: 187–192.

    PubMed  CAS  Google Scholar 

  18. Chen J, Tan KP, Ward WE & Thompson LU (2003) Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp. Biol. Med. 228: 951–958.

    CAS  Google Scholar 

  19. Chen J & Thompson LU (2003) Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res. Treat. 80: 163–170.

    PubMed  CAS  Google Scholar 

  20. Chiu PY, Mak DH, Poon MK & Ko KM (2002) In vivo anti-oxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone-containing extract of Polygonum root in comparison with schisandrin B and emodin. Planta Med. 68: 951–956.

    PubMed  CAS  Google Scholar 

  21. Cho MK, Park JW, Jang YP, Kim YC & Kim SG (2002) Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-k Ba phosphorylation and of p65 nuclear translocation in macrophages. Int. J. Immunopharmacol. 2: 105–116.

    CAS  Google Scholar 

  22. Clark WF, Kortas C, Heidenheim AP, Garland J, Spanner E & Parbtani A (2001) Flaxseed in Lupus Nephritis: A two-year no-placebo controlled crossover study. J. Am. Coll. Nutr. 20: 143–148.

    PubMed  CAS  Google Scholar 

  23. Clark WF & Ogborn M (2003) Flaxseed and flaxseed lignans: Effects on the progression and severity of renal failure. In AD Muir and ND Westcott (eds.) Flax: The Genus Linum (pp. 214–229). Taylor & Francis, London.

    Google Scholar 

  24. Clark WF, Parbtani A, Huff MW, Spanner E, De Salis H, Chin-Yee I, Philbrick DJ & Holub BJ (1995) Flaxseed: A potential treatment for lupus nephritis. Kidney Int. 48: 475–480.

    PubMed  CAS  Google Scholar 

  25. Collins TF, Sprando RL, Black TN, Olejnik N, Wiesenfeld PW, Babu US, Bryant M, Flynn TJ & Ruggles DI (2003) Effects.414 of flaxseed and defatted flaxseed meal on reproduction and development in rats. Food Chem. Toxicol. 41: 819–834.

    PubMed  CAS  Google Scholar 

  26. Dabrosin C, Chen J, Wang L & Thompson LU (2002) Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett. 185: 31–37.

    PubMed  CAS  Google Scholar 

  27. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R & Strauss BJ (1998) Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1: 124–129.

    Google Scholar 

  28. Davies MJ, Bowey EA, Adlecreutz H, Rowland IR & Rumsby PC (1999) Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 20: 927–931.

    PubMed  CAS  Google Scholar 

  29. Day SH, Lin YC, Tsao ML, Tsao LT, Ko HH, Chung MI, Lee JC, Wang JP, Won SJ & Lin CN (2002) Potent cytotoxic lignans from Justicia procumbens and their effects on nitric oxide and tumor necrosis factor-alpha production in mouse macrophages. J. Nat. Prod. 65: 379–381.

    PubMed  CAS  Google Scholar 

  30. De Leon EJ, Olmedo DA, Solis PN, Gupta MP & Terencio MC (2002) Diayangambin exerts immunosuppressive and anti-inflammatory effects in vitro and in vivo. Planta Med. 68: 1128–1131.

    PubMed  CAS  Google Scholar 

  31. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M & Vollmer RT (2001) Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58: 47–52.

    PubMed  CAS  Google Scholar 

  32. Di Padova C, Bosisio E, Cighetti G, Rovagnati P, Mazzocchi M, Colombo C & Tritapepe R (1982) 3-Hydroxy-3-methyl-glutaric acid (HMGA) reduces dietary cholesterol induction of saturated bile in hamster. Life Sci. 30: 1907–1914.

    PubMed  CAS  Google Scholar 

  33. Duthie GG & Brown KM (1994) Reducing the risk of cardiovascular disease. In I Goldberg (ed.) Functinal foods, designer foods, pharmafoods, nutraceuticals Chapman & Hall, New York.

    Google Scholar 

  34. Endoh D, Okui T, Ozawa S, Yamato O, Kon Y, Arikawa J & Hayashi M(2002) Protective effect of a lignan-containing flaxseed extract against CCl(4)-induced hepatic injury. J. Vet. Med. Sci. 64: 761–765.

    PubMed  CAS  Google Scholar 

  35. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klemoner MS, Weber PC & et al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New Eng. J. Med. 320: 265–271.

    PubMed  CAS  Google Scholar 

  36. Evans BAJ, Griffiths K & Morton MS (1995) Inhibition of 5 a-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 147: 295–302.

    PubMed  CAS  Google Scholar 

  37. Fisher M, Levine PH, Weiner BH, Johnson MH, Doyle EM, Ellis PA & Hoogasian JJ (1990) Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am. J. Clin. Nutr. 51: 804–808.

    PubMed  CAS  Google Scholar 

  38. Ford JD, Huang KS, Wang HB, Davin LB & Lewis NG (2001) Biosynthetic pathway to the cancer chemopreventive secoisolariciresinol diglucoside-hydroxymethl glutaryl esterlinked lignan oligomers in flax (Linum usitatissimum,) seed. J. Nat. Prod. 64: 1388–1397.

    PubMed  CAS  Google Scholar 

  39. Garreau B, Vallette G, Adlercreutz H, Wähälä K, Mäkelä T, Benassayag C & Nunez EA (1991) Phytoestrogens: new ligands for rat and human alpha-fetoprotein. Biochem. Biophys. Acta 1094: 339.

    PubMed  CAS  Google Scholar 

  40. Glitso LV, Mazur WM, Adlercreutz H, Wahala K, Makela T, Sandstrom B & Bach Knudsen KE (2000) Intestinal metabolism of rye lignans in pigs. Br. J. Nutr. 84: 429–437.

    PubMed  CAS  Google Scholar 

  41. Gordaliza M, Castro MA, del Corral JM & Feliciano AS (2000) Antitumor properties of podophyllotoxin and related compounds. Curr. Pharm. Des. 6: 1811–1839.

    PubMed  CAS  Google Scholar 

  42. Haggans CJ, Hutchins AM, Olson AM, Thomas W, Martini MC & Slavin JL (1999) Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr. Cancer 33: 188–195.

    PubMed  CAS  Google Scholar 

  43. Hall AV, Parbtani A, Clark WF, Spanner E, Keeney M, Chin-Yee I, Philbrick DJ & Holub BJ (1993) Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. Am. J. Kidney Dis. 22: 226–332.

    Google Scholar 

  44. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, Deyama T, Nishibe S & Adlercreutz H (2001) In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J. Agric. Food Chem. 49: 3178–3186.

    PubMed  CAS  Google Scholar 

  45. Hemmings SJ & Barker L (2004) The effects of dietary flaxseed on the Fischer 344 rat: I. Development, behaviour, toxicity and the activity of liver gamma-glutamyltranspeptidase. Cell Biochem. Funct. 22: 113–121.

    PubMed  CAS  Google Scholar 

  46. Hemmings SJ, Westcott ND, Muir AD & Czechowicz D (2004) The effects of dietary flaxseed on the Fisher344 rat: II. liver γ-glutamyltranspeptidase. Cell Biochem. Funct. 22: 225–231.

    PubMed  CAS  Google Scholar 

  47. Hibasami H, Fujikawa T, Takeda H, Nishibe S, Satoh T, Fujisawa T & Nakashima K (2000) Induction of apoptosis by Acanthopanax senticosus HARMS and its component, sesamin in human stomach cancer KATO III cells. Oncol. Rep. 7: 1213–1216.

    PubMed  CAS  Google Scholar 

  48. Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, Kono T, Nishibe S & Shirai T (2000) Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcino-genesis in male F344 rats. Cancer Lett. 155: 79–88.

    PubMed  CAS  Google Scholar 

  49. Hoang VD, Tan GT, Zhang HJ, Tamez PA, Hung NV, Cuong NM, Soejarto DD, Fong HH & Pezzuto JM (2002) Natural anti-HIV agents-part I: (+)-demethoxyepiexcelsin and verticillatol from Litsea verticillata. Phytochemistry 59: 325–329.

    PubMed  CAS  Google Scholar 

  50. Horn-Ross PL, Hoggatt KJ & Lee MM (2002) Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol. Biomarkers Prev. 11: 43–49.

    CAS  Google Scholar 

  51. Hulten K, Winkvist A, Lenner P, Johansson R, Adlercreutz H & Hallmans G (2002) An incident case-referent study on plasma enterolactone and breast cancer risk. Eur. J. Nutr. 41: 168–176.

    PubMed  CAS  Google Scholar 

  52. Hutchins AM, Martini MC, Olson BA, Thomas W & Slavin JL (2001) Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr. Cancer 39: 58–65.

    PubMed  CAS  Google Scholar 

  53. Hutchins AM & Slavin JL (2003) Effects of flaxseed on sex hormone metabolism. In LU Thompson and SC Cunnane (eds.) 2nd ed. Flaxseed in Human Nutrition (pp. 126–149). AOCS Press, Champaign, IL.

    Google Scholar 

  54. Ikeda S, Tohyama T & Tamashita K (2002) Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl-2(2-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-tocopherol. J. Nutr 132: 961–966.

    PubMed  CAS  Google Scholar 

  55. Imbert TF (1998) Discovery of podophyllotoxins. Biochimie 80: 207–222.

    PubMed  CAS  Google Scholar 

  56. Ingram AJ, Parbtani A, Clark WF, Spanner E, Huff MW, Philbrick DJ & Holub BJ (1995) Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. Am. J. Kidney Dis. 25: 320–329.

    PubMed  CAS  Google Scholar 

  57. Ingram D, Sanders K, Kolybaba M & Lopez D (1997) Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990–994

    PubMed  CAS  Google Scholar 

  58. Ito C, Itoigawa M, Ogata M, Mou XY, Tokuda H, Nishino H & Furukawa H (2001) Lignans as anti-tumor-promoter from the seeds of Hernandia ovigera. Planta Med. 67: 166–168.

    PubMed  CAS  Google Scholar 

  59. Jenab M, Richard SE, Orcheson LJ & Thompson LU (1999) Flaxseed and lignans increase cecal b-glucuronidase activity in rats. Nutr. Cancer 33: 154–158.

    PubMed  CAS  Google Scholar 

  60. Jensen JF, Kvist LP & Christensen SB (2002) An antiplasmodial lignan from Euterpe precatoria. J. Nat. Prod. 65: 1915–1917.

    PubMed  CAS  Google Scholar 

  61. Kamal-Eldin A, Peerlkamp N, Johnsson P, Andersson R, Andersson RF, Lundgren LN & Aman P (2001) An oligomer from flaxseed composed of secoisolariciresinol diglucoside and 3-hydroxy-3-methyl glutaric acid residues. Phytochemistry 58: 587–590.

    PubMed  CAS  Google Scholar 

  62. Kangas L, Saarinen N, Mutanen M, Ahotupa M, Hirsinummi R, Unkila M, Perala M, Soininen P, Lattikainen R, Korte H & Santti R (2002) Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce.Eur. J. Cancer Prev. 11 Suppl 2: S48–S57.

    PubMed  Google Scholar 

  63. Kelly MG & Hartwell JL (1954) The biological effects and the chemical composition of podophyllin: a review. J. Nat. Canc. Inst. 14: 967–1010.

    CAS  Google Scholar 

  64. Kitts DD, Yuan YV, Wijeckremene AN & Thompson LU (1999) Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol. Cell. Biochem. 202: 91–100.

    PubMed  CAS  Google Scholar 

  65. Kraft C, Jenett-Siems K, Kohler I, Tofern-Reblin B, Siems K, Bienzle U & Eich E (2002) Antiplasmodial activity of sequilignans and sesquineolignans from Bonamia spectabilis. Phytochemistry 60: 167–173.

    PubMed  CAS  Google Scholar 

  66. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B & Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252–4263.

    PubMed  CAS  Google Scholar 

  67. Lambert JD, Meyers RO, Timmermann BN & Dorr RT (2001) Tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo. Cancer Lett. 171: 47–56.

    PubMed  CAS  Google Scholar 

  68. Landstrom M, Zhang JX, Hallmans G, Aman P, Bergh A, Damber JE, Mazur W, Wahala K & Adlercreutz H (1998) Inhibitory Effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36: 151–161.

    PubMed  CAS  Google Scholar 

  69. Lee C, Kim H & Kho Y (2002) Agastinol and agastenol, novel Lignans from Agastache rugosa and their evaluation in an apoptosis inhibition assay. J. Nat. Prod. 65: 414–416.

    PubMed  CAS  Google Scholar 

  70. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, III, Spur BW, Robinson DR, Corey EJ, Lewis RA & Austen KF (1985) Effect of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leuko-triene generation and neutrophil function. New Eng. J. Med. 312: 1217–1224.

    PubMed  CAS  Google Scholar 

  71. Lemay A, Dodin S, Kadri N, Jacques H & Forest JC (2002) Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet. Gynecol. 100: 495–504.

    PubMed  CAS  Google Scholar 

  72. Li D, Yee JA, Thompson LU & Yan L (1999) Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice. Cancer Lett. 142: 91–96.

    PubMed  CAS  Google Scholar 

  73. Lianniang L, Hung X & Rui T (1985) Dibenzocyclooctadiene lignans from roots and stems of Kadsura coccinea. Med. 51: 297–300.

    Google Scholar 

  74. Lin X, Gingrich JR, Bao W, Li J, Horoon ZA & Demark-Wahnefried W (2002) Effect of flaxseed supplementation on prostatic car-cinoma in transgenic mice. Urology 60: 919–924.

    PubMed  Google Scholar 

  75. Lucas EA, Lightfoot SA, Hammond JL, Devareddy L, Khalil DA, Daggy BP, Smith BJ, Westcott N, Mocanu V, Soung do Y & Arjmandi BH (2004) Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 173: 223–229.

    PubMed  CAS  Google Scholar 

  76. Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, Stoecker BJ & Arjmandi BH (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in post-menopausal women. J. Clin. Endocrinol. Metab. 87: 1527–1532.

    PubMed  CAS  Google Scholar 

  77. Martin M, Haourigui M, Pelissero C, Benassayag C & Nunez E (1995) Interactions between phytoestrogens and human sex steroid binding protein. Life Science 58: 429–436.

    CAS  Google Scholar 

  78. Mazur W, Fotsis T, Wähälä K, Ojala S, Salakka A & Adlercreutz H (1996) Isotope Dilution Gas Chromatographic-Mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal. Biochem. 233: 169–180.

    PubMed  CAS  Google Scholar 

  79. Meagher LP, Beecher GR, Flanagan VP & Li BW (1999) Isolation and characterization of the lignans, isolariciresinol and pinoresinol, in flaxseed meal. J. Agric. Food Chem. 47: 3173–3180.

    PubMed  CAS  Google Scholar 

  80. Meragelman KM, McKee TC & Boyd MR (2001) 10-Demethoxystegane, a new lignan from Steganotaenia araliacea. J. Nat. Prod. 64: 1480–1482.

    PubMed  CAS  Google Scholar 

  81. Moorjani S & Lupien PJ (1977) Effect in vitro of 3-hydroxy-3-methylglutaric acid on the synthesis of mevalonate and its precursors. Arch. Int. Physiol. Biochim. 85: 1–10.

    PubMed  CAS  Google Scholar 

  82. Mousavi Y & Adlercreutz H (1992) Enterolactone and estradiol inhibit each other’s proliferative effect on MCF-7 breast cancer cells in culture. J. Steroid Biochem. Mol. Biol. 41: 615–619.

    PubMed  CAS  Google Scholar 

  83. Nakano D, Itoh C, Takaoka M, Kiso Y, Tanaka T & Matsumura Y (2002) Antihypertensive effect of sesamin. IV. Inhibition of vascular superoxide production by sesamin. Biol. Pharm. Bull. 25: 1247–1249.

    PubMed  CAS  Google Scholar 

  84. National Library of Medicine (2003) PubMed. http://www.ncbi.nlm.nih.gov/PubMed/

  85. Navarro E, Alonso SJ, Alonso PJ, Trujillo J, Jorge E & Perez C (2001) Pharmacological effects of elenoside, an arylnaphthalene lignan. Biol. Pharm. Bull. 24: 254–258.

    PubMed  CAS  Google Scholar 

  86. Nice D (1997) Antioxidant based nutraceuticals. In M Yalpani (ed.) New Technologies for Healthy Foods and Nutrition (pp. 105–123). ATL Press, Shresbury, MA

    Google Scholar 

  87. Ntiamoah C & Rowland GG (1997) Inheritance and characterization of two low linolenic acid EMS-induced McGregor mutant flax (Linum usitatissimum,). Can. J. Plant Sci. 77: 353–358.

    Google Scholar 

  88. Ogborn MR (2003) Flaxseed and flaxseed products in kidney disease. In LU Thompson and SC Cunnane (eds.) 2nd ed. Flaxseed in Human Nutrition (pp. 301–318). AOCS Press, Champaign, IL

    Google Scholar 

  89. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA & Aukema H (2002) Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n-6/n-3 FA ratio in experimental polycystic kidney disease. Lipids 37: 1059–1065.

    PubMed  CAS  Google Scholar 

  90. Ogborn MR, Nitschmann E, Weiler H, Leswick D & Bankovic-Calic N (1999) Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease. Kidney Int. 55: 417–423.

    PubMed  CAS  Google Scholar 

  91. Oikarinen S, Heinonen S, Karppinen S, Matto J, Adlercreutz H, Poutanen K & Mutanen M(2003) Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions. Br. J. Nutr. 90: 119–125.

    PubMed  CAS  Google Scholar 

  92. Parbitani A & Clark WF (1995) Flaxseed and Its Components in Renal Disease. In SC Cunnane and LU Thompson (eds.) Flaxseed in Human Nutrition (pp. 244–260). AOCS Press, Champaign, IL.

    Google Scholar 

  93. Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M & Adlercreutz H (2001) Serum enterolactone and risk of breast Cancer: a case-control study in eastern Finland. Cancer Epidemiol. Biomarkers Prev. 10: 339–344.

    PubMed  CAS  Google Scholar 

  94. Pizzorno JE, Jr & Murray MT (1999) Textbook of Natural Medicine. Churchill Livingstone, Edinburgh.

    Google Scholar 

  95. Pradheepkumar CP, Panneerselvam N & Shanmugam G (2000) Cleistanthin A causes DNA strand breaks and induces apoptosis in cultured cells. Mutat. Res. 464: 185–193.

    PubMed  CAS  Google Scholar 

  96. Prasad K (1997a) Dietary flaxseed in the prevention of hypercholes-terolemic atherosclerosis. Atherosclerosis 132: 69–75.

    PubMed  CAS  Google Scholar 

  97. Prasad K (1997b) Hydroxyl radical scavenging property of secoisol-ariciresinol diglucoside (SDG) isolated from flaxseed. Mol. Cell. Biochem. 168: 117–123.

    PubMed  CAS  Google Scholar 

  98. Prasad K (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99: 1355–1362.

    PubMed  CAS  Google Scholar 

  99. Prasad K (2000) Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG). Mol. Cell. Biochem. 209: 89–96.

    PubMed  CAS  Google Scholar 

  100. Prasad K (2001) Secoisolariciresinol diglucoside from flaxseed delays the development of type2 diabetes in Zucker rat. J. Lab. Clin. Med. 138: 32–39.

    PubMed  CAS  Google Scholar 

  101. Prasad K (2002) Suppression of phosphoenolpyruvate carboxykinase gene expression by secoisolariciresinol diglucoside (SDG), a new antidiabetic agent. Int. J. Angiol. 11: 107–109.

    CAS  Google Scholar 

  102. Prasad K & Kalra J (1993) Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am. Heart J. 125: 958–973.

    PubMed  CAS  Google Scholar 

  103. Prasad K, Kalra J & Lee P (1994) Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of Probucol. Int. J. Angiology 3: 100–112.

    Google Scholar 

  104. Prasad K, Mantha SV, Kalra J, Kapoor R & Kamalarajan BRC (1997a) Purpurogallin in the prevention of hypercholesterolemic atherosclerosis. Int. J. Angiology 6: 157–166.

    Google Scholar 

  105. Prasad K, Mantha SV, Kalra J & Lee P (1997b) Prevention of hypercholesterolemic atherosclerosis by garlic, an antioxidant. J. Cardiovasc. Pharmacol. Ther. 2: 309–320.

    PubMed  Google Scholar 

  106. Prasad K, Mantha SV, Kalra J, Muir AD & Westcott ND (1998) Reduction of hypercholerterolemic atherosclerosis by CDC-flaxseed with very low á-linolenic acid. Atherosclerosis 136: 367–375.

    PubMed  CAS  Google Scholar 

  107. Prasad K, Mantha SV, Muir AD & Westcott ND (2000) Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol. Cell. Biochem. 206: 141–149.

    PubMed  CAS  Google Scholar 

  108. Ranich T, Bhathena SJ & Velasquez MT (2001) Protective effects of dietary phytoestrogens in chronic renal disease. J Ren Nutr 11: 183–193.

    PubMed  CAS  Google Scholar 

  109. Rickard SE, Yuan YV, Chen J & Thompson LU (1999) Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr. Cancer 35: 50–57.

    PubMed  CAS  Google Scholar 

  110. Rickard-Bon SE & Thompson LU (2003) The role of flaxseed Lignans in hormone-dependent and independent cancer. In AD Muir and ND Westcott (eds.) Flax: The Genus Linum (pp. 181–203). Taylor & Francis, London.

    Google Scholar 

  111. Roberts LJ Morrow JD (2000) Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28: 505–513.

    PubMed  CAS  Google Scholar 

  112. Saarinen N, Makkela S & Santti R (2003) Mechanisms of anticancer effects of lignans with special emphasis on breast cancer. In LU Thompson and SC Cunnane (eds.) 2nd ed. Flaxseed in Human Nutrition (pp. 223–232). AOCS Press, Champaign, IL.

    Google Scholar 

  113. Saarinen NM, Huovinen R, Warri A, Makela SI, Valentin-Blasini L, Needham L, Eckerman C, Collan YU & Santti R (2001) Uptake and metabolism of hydroxymatairesinol in relation to its anticar-cinogenicity in DMBA-induced rat mammary carcinoma model. Nutr. Cancer 41: 82–90.

    PubMed  CAS  Google Scholar 

  114. Saarinen NM, Huovinen R, Warri A, Makela SI, Valentin-Blasini L, Sjoholm R, Ammala J, Lehtila R, Eckerman C, Collan YU & Santti RS (2002a) Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat. Mol. Cancer Ther. 1: 869–876.

    PubMed  CAS  Google Scholar 

  115. Saarinen NM, Smeds A, Makela SI, Ammala J, Hakala K, Pihlava JM, Ryhanen EL, Sjoholm R & Santti R (2002b) Structural determinants of plants lignans for the formation of enterolactone in vivo. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 777: 311–319.

    PubMed  CAS  Google Scholar 

  116. Saarinen NM, Warri A, Makela SI, Eckerman C, Reunanen M, Ahotupa M, Salmi SM, Franke AA, Kangas L & Santti R (2000) Hydroxymatairesinol, a novel enterolactone precursor with anti-tumor properties from coniferous tree (Picea abies). Nutr. Cancer 36: 207–216.

    PubMed  CAS  Google Scholar 

  117. Satyanarayana V, Krupadanam GL & Srimannarayana G (1991) A butyrolactone lignan disaccharide from Flacourtia ramontchi. Phytochemistry 30: 1026–1029.

    PubMed  CAS  Google Scholar 

  118. Schumacher B, Scholle S, Holzl J, Khudeir N, Hess S & Muller CE (2002) Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors. J. Nat. Prod. 65: 1479–1485.

    PubMed  CAS  Google Scholar 

  119. Serraino M & Thompson LU (1992) Flaxseed supplementation and early markers of colon carcinogenesis. Cancer Lett. 63: 159–165.

    PubMed  CAS  Google Scholar 

  120. Setchell KDR (1995) Discovery and potential clinical importance of mammalian lignans. In SC Cunnane and LU Thompson (eds.) Flaxseed in Human Nutrition (pp. 82–98). AOCS Press, Champaign, Ill.

    Google Scholar 

  121. Setchell KDR, Bull R & Adlercreutz H (1980a) Steroid excretion during the reproductive cycle and pregnancy of the velvet monkey (Ceropithecus aethiopus pygerythrus,). J. Steroid Biochem. 12: 375–384.

    PubMed  CAS  Google Scholar 

  122. Setchell KDR, Lawson AM, Borriello SP, Harkness R, Gordon H, Morgan DML, Kirk DN, Adlercreutz H, Anderson LC & Axelson M (1981a) Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet ii: 4–7.

    Google Scholar 

  123. Setchell KDR, Lawson AM, Conway E, Taylor NF, Kirk DN, Cooley G, Farrant RD, Wynn S & Axelson M (1981b) The definite identification of the lignans trans-2,3-bis(3-hydroxybenzyl-γ-butyrolactone and 2,3-bis(3-hydroxybenzyl)butane-1,4-diol in human and animal urine. Biochem. J. 197: 447–458.

    PubMed  CAS  Google Scholar 

  124. Setchell KDR, Lawson AM, Conway E, Taylor NF, Kirk DN, Cooley G, Farrant RD, Wynn S & Axelson M (1981c) The definite identification of the lignans trans,-2,3-bis(3-hydroxybenzyl-g-butyrolactone and 2,3-bis(3-hydroxybenzyl)butane-1,4-diol in human and animal urine. Biochemistry Journal 197: 447–458.

    CAS  Google Scholar 

  125. Setchell KDR, Lawson AM, Mitchell FL, Adlecreutz H, Kirk DN & Axelson M (1980b) Lignans in Man and Animal species. Nature 287: 740–742.

    PubMed  CAS  Google Scholar 

  126. Shen TY & Hussaini IM (1990) Kadsurenone and other related Lignans as antagonists of platelet-activating factor receptor. In RC Murphy and FA Fitzpatrick (eds.) Arachidonate Related Lipid Mediators (pp. 446–454). Academic Press, Inc., San Diego, CA.

    Google Scholar 

  127. Sprando RL, Collins TF, Black TN, Olejnik N, Rorie JI, Scott M, Wiesenfeld P, Babu US & O’Donnell M (2000a) The effect of maternal exposure to flaxseed on spermatogenesis in F(1) generation rats. Food Chem. Toxicol. 38: 325–334.

    PubMed  CAS  Google Scholar 

  128. Sprando RL, Collins TF, Wiesenfeld P, Babu US, Rees C, Black T, Olejnik N & Rorie J (2000b) Testing the potential of flaxseed to affect spermatogenesis: morphometry. Food Chem. Toxicol. 38: 887–892.

    PubMed  CAS  Google Scholar 

  129. Sprando RL, Collins TFX & Wiesenfeld PW (2003) Effect of flaxseed consumption on make and female reproductive function and fetal development. In LU Thompson and SC Cunnane (eds.) 2nd.417 ed. Flaxseed in Human Nutrition (pp. 341–362). AOCS Press, Champaign, IL.

    Google Scholar 

  130. Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J & Hakama M (2002) Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int. J. Cancer 99: 124–129.

    PubMed  CAS  Google Scholar 

  131. Stitch SR, Smith PD, Illingworth D & Toumba K (1980a) Cyclic excretion of a non-steroidal compound in woman. J. Endocrinol. 85: 23P.

    Google Scholar 

  132. Stitch SR, Toumba JK, Groen MB, Funke CW, Leemhuis J, Vink GF & Wood GF (1980b) Excretion, isolation and structure of a new phenolic constituent in female urine. Nature 287: 738–740.

    PubMed  CAS  Google Scholar 

  133. Sung M-K, Lautens M & Thompson LU (1998) Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Res. 18: 1405–1408.

    PubMed  CAS  Google Scholar 

  134. Takasaki M, Konoshima T, Komatsu K, Tokuda H & Nishino H (2000) Anti-tumor-promoting activity of lignans from the aerial part of Saussurea medusa. Cancer Lett. 158: 53–59.

    PubMed  CAS  Google Scholar 

  135. Takashima J, Asano S & Ohsaki A (2002) Mururins A-C, three new lignoids from Brosimum acutifolium and their protein kinase inhibitory activity. Planta Med. 68: 621–625.

    PubMed  CAS  Google Scholar 

  136. Tan KP, Chen J, Ward WE & Thompson LU (2004) Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp. Biol. Med. 229: 147–157.

    CAS  Google Scholar 

  137. Thompson LU (2003) Flaxseed, Lignans, and Cancer. In LU Thompson and SC Cunnane (eds.) 2nd ed. Flaxseed in Human Nutrition (pp. 194–222). AOCS Press, Champaign, IL.

    Google Scholar 

  138. Thompson LU, Rickard SE, Orcheson LJ & Seidl MM (1996a) Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17: 1373–1376.

    PubMed  CAS  Google Scholar 

  139. Thompson LU, Robb P, Serraino M & Cheung F (1991) Mammalian lignan production from various foods. Nutr. Cancer 16: 43–52.

    PubMed  CAS  Google Scholar 

  140. Thompson LU, Seidl MM, Rickard SE, Orcheson LJ & Fong HHS (1996b) Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr. Cancer 26: 159–165.

    PubMed  CAS  Google Scholar 

  141. Tibirica E (2001) Cardiovascular properties of Yangambin, a lignan isolated from Brazilian plants. Cardiovasc. Rev. 19: 313–328.

    CAS  Google Scholar 

  142. Tou J, Chen J & Thompson LU (1998) The importance of timing of exposure to flaxseed on reproductive development of rats. In: Ann. Meet. Prof. Res. Sci. Expt. Biol. 98, April 18–22, 1998, 12 pp. A768. San Francisco FASEB Journal.

  143. Tou JC, Chen J & Thompson LU (1999) Dose, timing, and duration of flaxseed exposure affect reproductive indices and sex hormone levels in rats. Journal of toxicology and Environmental Health 56: 555–570.

    PubMed  CAS  Google Scholar 

  144. Tsukamoto H, Hisada S & Nishide S (1984) Lignans from bark of Fraxinus mandshurica var. japonica and J. japonica. Chem. Pharm Bull (Tokyo) 32: 4482–4489.

    CAS  Google Scholar 

  145. van Kranen HJ, Mortensen A, Sorensen IK, van den Berg-Wijnands J, Beems R, Nurmi T, Adlercreutz H & van Kreijl CF (2003) Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice. Nutr. Cancer 45: 203–210.

    PubMed  CAS  Google Scholar 

  146. Vanharanta M, Mursu J, Nurmi T, Voutilainen S, Rissanen TH, Salonen R, Adlecreutz H & Salonen JT (2002a) Phloem fortification in rye bread elevates serum enterolactone level. Eur. J. Clin. Nut. 56: 952–957.

    CAS  Google Scholar 

  147. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H & Salonen JT (1999) Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354: 2112–2115.

    PubMed  CAS  Google Scholar 

  148. Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts LJ, Morrow JD, Adlercreutz H & Salonen JT (2002b) Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 160: 465–469.

    PubMed  CAS  Google Scholar 

  149. Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H & Salonen JT (2003) Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch. Intern. Med. 163: 1099–1104.

    PubMed  CAS  Google Scholar 

  150. Velasquez MT & Bhathena SJ (2001) Dietary phytoestrogens: a possible role in renal disease protection. Am. J. Kidney Dis. 37: 1056–1068.

    PubMed  CAS  Google Scholar 

  151. Wang C & Kurzer MS (1997) Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr. Cancer 28: 236–247.

    PubMed  CAS  Google Scholar 

  152. Wang C & Kurzer MS (1998) Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr. Cancer 31: 90–100.

    PubMed  CAS  Google Scholar 

  153. Wang C, Mäkelä T, Hase T, Adlercreutz H & Kurzer MS (1994) Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J. Steroid Biochem. Molec. Biol. 50: 205–212.

    PubMed  CAS  Google Scholar 

  154. Wang W, Liu LQ, Higuchi CM & Chen H (1998) Induction of NADPH: quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem. Pharmacol. 56: 189–195.

    PubMed  Google Scholar 

  155. Ward WE (2003) Effect of flaxseed on bone metabolism and menopause. In LU Thompson and SC Cunnane (eds.) 2nd ed. Flaxseed in Human Nutrition (pp. 319–332). AOCS Press, Champaign, IL.

    Google Scholar 

  156. Ward WE, Yuan YV, Cheung AM & Thompson LU (2001a) Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats. J Toxicol Environ Health A 63: 53–65.

    PubMed  CAS  Google Scholar 

  157. Ward WE, Yuan YV, Cheung AM & Thompson LU (2001b) Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br. J. Nutr. 86: 499–505.

    PubMed  CAS  Google Scholar 

  158. Welshons WV, Murphy CS, Koch R, Calaf G & Jordan VC (1987) Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res. Treat. 10: 169–175.

    PubMed  CAS  Google Scholar 

  159. Westberg G, Tarkowski A & Svalander C (1989) Effect of eicosapentaenoic acid rich menhaden oil and MaxEPA on the autoimmune disease of Mrl/l mice. Int. Arch. Allergy Appl. Immunol. 88: 454–461.

    PubMed  CAS  Google Scholar 

  160. Westcott ND & Muir AD (1996) Variation in the concentration of the flax seed lignan concentration with variety, location and year. In: J Carter (ed.) Proc. Flax Inst. USA, Vol. 56 pp. 77–80. Fargo, ND Flax Institute of the United States.

  161. Westcott ND & Muir AD (1998) Process for extracting lignans from flaxseed. USA patent 5705–5618.

  162. Wilcox G, Wahlqvist ML, Burger HG & Medley G (1990) Oestrogenic effects of plant foods in postmenopausal women. Brit. Med. J. 301: 905–906.

    PubMed  CAS  Google Scholar 

  163. Yan L, Lee JA, Li D, McGuire MH & Thompson LU (1998) Dietary Flaxseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett. 124: 181–186.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Westcott, N.D., Muir, A.D. Flax seed lignan in disease prevention and health promotion. Phytochemistry Reviews 2, 401–417 (2003). https://doi.org/10.1023/B:PHYT.0000046174.97809.b6

Download citation

  • atherosclerosis
  • cancer
  • diabetes
  • flax
  • lignans
  • Linum
  • liver
  • lupus
  • secoisolariciresinol diglucoside